About Sakura Finetek
Sakura Finetek is a company based in Torrance (United States) founded in 1986 by Takashi Tsuzuki. It operates as a B2B. Sakura Finetek has completed 1 acquisition, including Genemed Biotechnologies. Sakura Finetek offers products and services including Tissue-Tek Accu-Edge Grossing Stations, Microtome Blades, Reagents, and Staining Systems. Sakura Finetek operates in a competitive market with competitors including Evosep, Ovizio, Pressure BioSciences, Curiox and inveox, among others.
- Headquarter Torrance, United States
- Founders Takashi Tsuzuki
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Sakura Finetek Usa, Inc.
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
Not available
- Investments & Acquisitions
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Sakura Finetek
Sakura Finetek offers a comprehensive portfolio of products and services, including Tissue-Tek Accu-Edge Grossing Stations, Microtome Blades, Reagents, and Staining Systems.
Tools for preparing tissue samples in pathology labs.
Blades for precise sectioning of tissue specimens.
Substances used for tissue processing and staining.
Automated systems for slide staining in histology.
People of Sakura Finetek
Unlock access to complete
Funding Insights of Sakura Finetek
Detailed funding history for Sakura Finetek
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Sakura Finetek
Sakura Finetek has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Genemed Biotechnologies.
Investment portfolio details for Sakura Finetek
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
IVD reagents for diagnostics are manufactured and marketed globally.
|
Locked | Locked | 1987 | Locked |
Complete acquisition details for Sakura Finetek
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - Sakura Finetek
Detailed financials for Sakura Finetek
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Sakura Finetek Comparisons
Peer comparison for Sakura Finetek
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Sakura Finetek
Sakura Finetek operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Evosep, Ovizio, Pressure BioSciences, Curiox and inveox, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Solutions for clinical proteomics sample preparation are developed.
|
|
| Locked | Locked | Locked |
Imaging systems and AI software for microscopes are developed.
|
|
| Locked | Locked | Locked |
Biomolecular reactions are controlled via pressure cycling technology.
|
|
| Locked | Locked | Locked |
Wall-less plates and washers are developed for automated cell-based assays.
|
|
| Locked | Locked | Locked |
Automated solutions for biopsy sample preparation in laboratories are provided.
|
|
| Locked | Locked | Locked |
Magnetic resonance sensors for microscopic studies are developed.
|
Detailed competitors of Sakura Finetek
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Sakura Finetek
Complete news archive for Sakura Finetek
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Sakura Finetek
Sakura Finetek was founded in 1986.
Sakura Finetek is headquartered in Torrance, United States. It is registered at Torrance, California, United States.
Takashi Tsuzuki is the current CEO of Sakura Finetek. They have also founded this company.
Sakura Finetek USA, Inc. develops and supplies innovative tools for anatomic pathology, including grossing stations, microtomes, reagents, and staining systems. They focus on improving efficiency in tissue processing and diagnostics through advanced technology. Based in the Americas, the company serves laboratories and medical facilities globally, emphasizing quality and customer support in histopathology workflows.
Sakura Finetek offers Tissue-Tek Accu-Edge Grossing Stations, Microtome Blades, Reagents, and Staining Systems.
Sakura Finetek has made 1 acquisition, including Genemed Biotechnologies.